跳至主要内容
临床试验/NCT07739342
NCT07739342尚未招募不适用

Evaluating the Occurrence of DKA in People With Type 1 Diabetes

Abbott Diabetes Care7 个研究点 分布在 1 个国家目标入组 1,200 人开始时间: 2026年9月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
1,200
试验地点
7
主要终点
Primary Objective

研究概览

简要总结

This study will evaluate the occurrences of Diabetes-related Ketoacidosis (DKA) in adult and pediatric individuals living with Type I diabetes while managing diabetes with Abbott's Continuous Monitoring Systems.

详细描述

The purpose of this study is to understand the occurrence of DKA in people with type 1 diabetes which will subsequently inform the benefit of continuous glucose and ketone monitoring in this population.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
2 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Aged at least 2 years old at the time of study enrollment.
  • Diagnosis of type 1 diabetes with at least 12 months of diabetes medical history.
  • In the investigator's opinion, the participant is willing to wear the sensor, follow study specific instructions, and perform all study tasks.
  • Willing and able to provide written signed and dated informed consent (adults) or participant's parent/legal guardian must be willing and able to provide written signed and dated informed consent along with assent form completed by the participant for those mature enough to make their own decisions per investigator assessment (those less than 16 years of age).

排除标准

  • In the investigator's opinion, the participant has a known (or suspected) allergy to medical grade adhesives at enrollment that would interfere with participant completing study required activities.
  • In the investigator's opinion, the participant has concomitant medical condition(s) which could interfere with the study or present a risk to the safety or welfare of the participant or study staff.
  • Participant is currently in another clinical study which may affect glucose or ketone management (or does so during the study).
  • Participant is unsuitable for participation due to any other cause as determined by the investigator.
  • Participant has implanted medical devices such as pacemakers or requires dialysis or is critically ill.

结局指标

主要结局

Primary Objective

时间窗: 12 months

Occurrence of Diabetes-related Ketoacidosis (DKA) in adult and pediatric individuals living with type 1 diabetes while managing diabetes with the Abbott's Continuous Dual Glucose Ketone Monitoring System.

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (7)

Loading locations...

相似试验

Evaluating the Occurrence of DKA in People With Type... | 临床试验